This study systematically evaluated the dynamic changes of standard aPL antibodies and aPS/PT antibodies in APS-RPL patients before treatment, after treatment, and during early pregnancy, with the aim of elucidating the potential immunomodulatory mechanisms underlying pregnancy maintenance. This evidence concerns the gene FASLG and autoimmune polyendocrinopathy.